Clinical Study
Efficacy and Safety of a Stimulator Using Low-Intensity Pulsed Ultrasound Combined with Transcutaneous Electrical Nerve Stimulation in Patients with Painful Knee Osteoarthritis
Table 3
Differences between the groups for changes from baseline.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data are presented as mean (SE). . Bonferroni correction was applied to adjust the 2-time comparisons. ΔV1−V2, difference of values between visit 1 and visit 2; ΔV1−V3, difference of values between visit 1 and visit 3; CI; confidence interval; TENS, transcutaneous electrical nerve stimulation; LIPUS, low-intensity pulsed ultrasound; VAS, visual analogue scale (range, 1 to 10), with higher values indicating worse outcomes; VAS-P1, visual analogue scale for knee pain at the current moment; VAS-P2, visual analogue scale for knee pain with movement; VAS-P3, visual analogue scale for knee pain at the resting position; WOMAC, Western Ontario and McMaster index with higher scores representing worse pain, stiffness, and impaired physical function; FAC, femoral articular cartilage; SF-36, the MOS 36-Item Short-Form Health Survey with a higher score indicating better health. |